|
SLC39A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.46593889541691E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.51740003579471E-09 |
| Normal-vs-Stage2 |
1.390890E-04 |
| Normal-vs-Stage3 |
1.380820E-04 |
| Normal-vs-Stage4 |
5.956700E-03 |
| Stage1-vs-Stage2 |
7.571000E-01 |
| Stage1-vs-Stage3 |
1.702270E-02 |
| Stage1-vs-Stage4 |
1.851810E-02 |
| Stage2-vs-Stage3 |
3.271900E-02 |
| Stage2-vs-Stage4 |
1.595370E-01 |
| Stage3-vs-Stage4 |
6.927800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.22475379732623E-12 |
| Normal-vs-AfricanAmerican |
2.26449999862766E-08 |
| Normal-vs-Asian |
1.763610E-01 |
| Caucasian-vs-AfricanAmerican |
4.299200E-01 |
| Caucasian-vs-Asian |
8.690000E-01 |
| AfricanAmerican-vs-Asian |
7.796400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.70740105282152E-11 |
| Normal-vs-Female |
4.81570006094501E-10 |
| Male-vs-Female |
9.511800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.59930000000119E-05 |
| Normal-vs-Extreme_Weight |
1.39100000406955E-08 |
| Normal-vs-Obese |
1.94549999998905E-07 |
| Normal-vs-Extreme_Obese |
1.443870E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.059600E-01 |
| Normal_Weight-vs-Obese |
7.320600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.190000E-01 |
| Extreme_Weight-vs-Obese |
1.706170E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.616800E-01 |
| Obese-vs-Extreme_Obese |
2.160600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.935690E-03 |
| Normal-vs-Age(41-60Yrs) |
1.14910303494753E-11 |
| Normal-vs-Age(61-80Yrs) |
2.67080002558373E-09 |
| Normal-vs-Age(81-100Yrs) |
1.768190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.395400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.937900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.984380E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.806350E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.004100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.340570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.08439931981275E-11 |
| Normal-VS-Type2 PRCC |
1.58841999999826E-05 |
| Normal-VS-KIRP CIMP |
1.543430E-03 |
| Normal-VS-Unclassified PRCC |
1.58329999999651E-06 |
| Type1 PRCC-VS-Type2 PRCC |
4.918600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.509570E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.475800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.148800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.492430E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.677600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.39550000000044E-05 |
| Normal-vs-N1 |
9.90990000000469E-05 |
| Normal-vs-N2 |
4.660300E-02 |
| N0-vs-N1 |
6.719600E-01 |
| N0-vs-N2 |
2.287400E-01 |
| N1-vs-N2 |
2.066200E-01 |
|
|
